Previous close | 179.35 |
Open | 179.60 |
Bid | 182.25 x 20000 |
Ask | 184.00 x 20000 |
Day's range | 179.60 - 182.15 |
52-week range | 126.40 - 218.20 |
Volume | |
Avg. volume | 24 |
Market cap | 27.077B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | 32.64 |
EPS (TTM) | 5.58 |
Earnings date | 25 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | 1.75 (0.98%) |
Ex-dividend date | 07 Feb 2024 |
1y target est | 261.67 |
36,000 people across 17 markets responded to the company’s fourth annual survey.40% of respondents get no more than three nights of good sleep per week.More than one-third of respondents are now actively tracking their sleep patterns, and many are adjusting bedtime routines in an effort to improve sleep quality. SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health and cloud-connected medical devices that transform care for people with sl
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...